Возраст домена | 24 года |
Дата окончания | Истек срок регистрации |
PR | 5 |
ИКС | 0 |
Страниц в Google | 2420 |
Страниц в Яндексе | 68 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 1408863 |
Alexa Country | Нет данных |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Drug Discovery Today - the magazine for the drug discovery professional: authoritative reviews and expert opinion; industry focused and peer reviewed.
n/a
Drug Discovery Today is a review journal, published as monthly 12 double issues. The journal covers the whole of the preclinical drug discovery process, from target identification and validation, through hit identification, lead identification and optimisation, though to candidate selection. The reviews are at the cutting edge of the science underpinning drug discovery, written by experts in their respective fields and cover all aspects of drug discovery from state-of-the-art genomic and proteom
UTF-8
44.02 КБ
1 420
11 492 симв.
9 773 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
wikipedia.org | 55 | 9 |
0 | 5 | 6 | |
nih.gov | 54 | 8 |
0 | 113 | 65 | |
sciencedaily.com | 39 | 8 |
0 | 3875 | 1533 | |
nature.com | 38 | 9 |
0 | 740 | 269 | |
sciencedirect.com | 26 | 9 |
0 | 172 | 94 | |
elsevier.com | 25 | 9 |
0 | 395 | 181 | |
medicalnewstoday.com | 23 | 6 |
0 | 1606 | 481 | |
discovery.com | 22 | 8 |
0 | 22210 | 5817 | |
discovermagazine.com | 16 | 7 |
0 | 21948 | 5653 | |
damonrunyon.org | 16 | 6 |
10 | 1819563 | 430988 | |
fastcompany.com | 3 | 7 |
0 | 2723 | 909 | |
discoverymedicine.com | 3 | 4 |
10 | 548185 | 228403 | |
breakthroughdigest.com | 3 | 4 |
10 | 21698713 | Нет данных | |
Еще 37 сайтов после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
Google Analytics | Нет доступа | Нет доступа | n/a |
Данные linkpad ( 15 Ноября 2016 ) | |
Количество ссылок на сайт | 496 |
Количество доменов, которые ссылаются на сайт | 81 |
Количество найденных анкоров | 48 |
Исходящие (внешние) ссылки домена | 3558 |
Количество доменов, на которые ссылается сайт | 119 |
Количество исходящих анкоров | 127 |
Внешние ссылки главной страницы ( 10 ) | |
sciencedirect.com/science/article/pii/S1359644614003997 | Peptide therapeutics: current status and future directions • Review article |
sciencedirect.com/science/article/pii/S135964461500077X | Bispecific antibodies • Review article |
sciencedirect.com/science/article/pii/S1359644614003894 | Designing novel building blocks is an overlooked strategy to improve compound quality • Review article |
sciencedirect.com/science?_ob=GatewayURL&_method=citationSea... | The road ahead for large pharma: long-term science and innovation • Editorial |
sciencedirect.com/science?_ob=GatewayURL&_method=citationSea... | The impact of aromatic ring count on compound developability - are too many aromatic rings a liability in drug design? • Review ... |
elsevier.com/ | Elsevier Ltd |
elsevier.com/wps/find/termsconditions.cws_home/termsconditio... | Terms & Conditions |
elsevier.com/wps/find/privacypolicy.cws_home/privacypolicy | Privacy |
intuitiv.net/ | Website Design |
workingwithwater.net/ | Working with water |
Внутренние ссылки главной страницы ( 56 ) | |
# | × |
/rss/ | RSS Alerts |
/the-magazine/ | The Magazine |
/related-publications/ | Related Publications |
/magazine-subscription/ | Magazine Subscription |
advertising.drugdiscoverytoday.com/2018.pdf | Advertising |
/submit-a-paper/ | Submit a Paper |
/contacts/ | Contacts |
/links/ | Links |
/omeda/register.aspx | Sign-Up |
newsletter.drugdiscoverytoday.com/ | Latest Issue |
/podcasts/ | view more |
/webinars/ | view more |
/downloads/ | view more |
/features/ | view more |
/news/ | view more |
/key-research-articles/ | Key Research Articles |
/category/208/biotherapeutics/ | Biotherapeutics |
/category/218/companies-and-people/ | Companies and People |
/category/215/drug-metabolism/ | Drug Metabolism |
/category/211/drug-trials/ | Drug Trials |
/category/217/informatics/ | Informatics |
/category/210/medicinal-chemistry/ | Medicinal Chemistry |
/category/214/novel-technologies/ | Novel Technologies |
/category/209/pharmacology-therapeutics/ | Pharmacology/ Therapeutics |
/category/212/regulatory/ | Regulatory |
/category/216/target-identification-validation/ | Target Identification/ Validation |
/category/262/the-view-from-here/ | The View From Here |
/events/ | Events & Training |
/view/47479/the-may-issue-of-drug-discovery-today-is-a-speci... | The May issue of Drug Discovery Today is a Special Issue and will be published very soon |
/view/47478/making-great-drugs-only-half-the-battle/ | Making great drugs – only half the battle? |
/view/47477/dundee-scientists-solve-3d-structure-of-key-prot... | Dundee scientists solve 3D structure of key protein involved in Intellectual Disability |
/view/47476/molecular-details-of-protein-crystal-nucleation-... | Molecular details of protein crystal nucleation uncovered |
/view/47475/elsevier-launches-mendeley-data/ | Elsevier launches Mendeley Data |
/listen/94/evotec-strengthens-and-expands-its-alliance-busin... | Evotec strengthens and expands its Alliance Business |
/listen/56/the-ubiquitin-story/ | The Ubiquitin Story |
/listen/59/califf-behrman-and-kramer-discuss-the-clinical-tr... | Califf, Behrman and Kramer discuss the Clinical Trials Transformation Initiative. |
/listen/60/dr-brent-vose-outlines-astrazenecas-oncology-pipe... | Dr Brent Vose outlines AstraZeneca's oncology pipeline. |
/webinar/314/the-promise-of-epigenetics-in-early-stage-drug-... | The Promise of Epigenetics in Early Stage Drug Discovery |
/webinar/313/integrated-quant-qual-for-in-vivo-discovery-bio... | Integrated Quant / Qual for In-vivo Discovery Bioanalysis using Hybrid Quadrupole-Time-of-Flight Mass Spectrometry |
/webinar/273/drug-delivery-enabling-technology-for-discovery... | Drug Delivery: enabling technology for discovery and development |
/webinar/274/part-2-how-has-hr-ms-technology-fundamentally-c... | Part 2: How has HR-MS technology fundamentally changed the way we study drug biotransformation and disposition? |
/view/44495/peptide-therapeutics-current-statusand-future-di... | Peptide therapeutics: current statusand future directions |
/view/33764/getting-the-most-out-of-your-ip-patent-managemen... | Getting the most out of your IP – patent management along its life cycle |
/view/24065/what-makes-a-good-drug-target/ | What makes a good drug target? |
/view/22986/drug-discovery-in-the-next-decade-innovation-nee... | Drug discovery in the next decade:innovation needed ASAP |
/download/1570 | Microfluidic technologies for anticancer drug studies |
/download/1571 | Human cell derived organoids as a new ex vivo model for drug assays in oncology |
/download/1572 | Exosomes a new horizon in lung cancer |
/download/1569 | The positive impacts of real world data on the challenges facing the evolution of biopharma |
/download/1565 | Interfering peptides targeting protein protein interactions the next generation of drugs |
/25-hottest-articles/ | view more |
/omeda/forgotten-password.aspx | Forgotten login? |
/register/ | Not a member? |
/sitemap/ | Sitemap |
/cookies/ | Find out more about cookies |
Domain Name: DRUGDISCOVERYTODAY.COM
Registry Domain ID: 22084418_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.safenames.net
Registrar URL: http://www.safenames.net
Updated Date: 2017-07-26T15:18:09Z
Creation Date: 2000-03-10T17:59:27Z
Registry Expiry Date: 2019-03-10T16:59:27Z
Registrar: SafeNames Ltd.
Registrar IANA ID: 447
Registrar Abuse Contact Email: abuse@safenames.net
Registrar Abuse Contact Phone: +44.1908200022
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS1.REEDELSEVIER.COM
Name Server: NS2.REEDELSEVIER.COM
Name Server: NS3.REEDELSEVIER.COM
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-11-29T05:59:59Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
США - 74.220.207.114
Unified Layer
Unified Layer
HTTP/1.1 200 OK
Cache-Control: private
Content-Type: text/html; charset=utf-8
Server: Microsoft-IIS/7.5
X-Powered-By: UrlRewriter.NET 2.0.0
Set-Cookie: ASP.NET_SessionId=leyvnwv3xcsequ2cgaz1j3qn; path=/; HttpOnly
X-AspNet-Version: 4.0.30319
X-Powered-By: ASP.NET
Date: Sun, 22 Apr 2018 14:20:08 GMT
Content-Length: 45081
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"